Marshall Wace
NTLA icon

Marshall Wace’s Intellia Therapeutics NTLA Stock Holding History

Marshall Wace’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.76M Buy
+137,425
New +$1.75M ﹤0.01% 1857
2025
Q1 		– Sell
-95,339
Closed -$1.11M – 2969
2024
Q4 		$1.11M Buy
+95,339
New +$1.49M ﹤0.01% 1687
2024
Q2 		– Sell
-335,408
Closed -$9.23M – 2857
2024
Q1 		$9.23M Sell
335,408
-555,090
-62% -$15.4M 0.02% 774
2023
Q4 		$27.2M Buy
+890,498
New +$25.6M 0.05% 387
2023
Q1 		– Sell
-389,074
Closed -$13.6M – 3012
2022
Q4 		$13.6M Buy
389,074
+381,674
+5,158% +$18.1M 0.04% 641
2022
Q3 		$414K Sell
7,400
-2,724
-27% -$169K ﹤0.01% 2809
2022
Q2 		$524K Sell
10,124
-96,192
-90% -$4.88M ﹤0.01% 2770
2022
Q1 		$7.73M Buy
+106,316
New +$9.01M 0.02% 1059
2021
Q3 		– Sell
-74,744
Closed -$12.1M – 3336
2021
Q2 		$12.1M Buy
74,744
+59,835
+401% +$4.66M 0.06% 394
2021
Q1 		$1.2M Buy
14,909
+1,443
+11% +$96.9K 0.01% 1573
2020
Q4 		$733K Buy
+13,466
New +$489K ﹤0.01% 1329
2016
Q3 		– Sell
-11,408
Closed -$244K – 1073
2016
Q2 		$244K Buy
+11,408
New +$304K ﹤0.01% 921

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return